Review
Sep 2026
Efficacy and Safety of Savolitinib Plus Osimertinib in EGFR-Mutant, MET-Aberrant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Combined therapy shows encouraging results in selected MET, post-TKI NSCLC, however, reliance on single-arm data warrants further randomized controlled trials.
Eshal Amir, M. W. Khan, M. Mannan et al.
· American Journal of Clinical... · 0 citations